In a remarkable display of bench to bedside science, a therapeutic developed by U-M’s Michelle Hastings, Ph.D. is now being used to treat twin girls with a rare form of juvenile Batten disease.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
